Molecular Characterization of Multiple Myeloma Ethnic Disparity
The goal of this funding opportunity is to determine the molecular characteristics of Multiple Myeloma (MM) in patients of Black ethnicity compared to those of White ethnicity. The project will support the FDA's scientific mission of protecting and promoting the public health by initiating and facilitating research into the observed differences in Blacks and the relevance to drug approval and future clinical trial design.
General information about this opportunity
Last Known Status
Deleted 08/20/2015 (Archived.)
Program Number
RFA-FD-15-029 Federal Agency/Office
Agency: Department of Health and Human ServicesOffice: Food and Drug Administration
Type(s) of Assistance Offered
Cooperative Agreement Number of Awards Available
1 Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Eligibility is limited to the Multiple Myeloma (MM) service of Memorial Sloan Kettering Cancer Institute. What is the process for applying and being award this assistance?
Deadlines
07/21/2015 Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements. Who do I contact about this opportunity?
Headquarters Office
Vieda HubbardGrants Management Specialist
Phone 240-402-7588
E-mail Address
vieda.hubbard@fda.hhs.gov
Financial Information
Obligations
$278,000.00 Range and Average of Financial Assistance
Awards range from $172,000.00 to $172,000.00
